Study Notes on Alzheimer's Disease and Related Neurocognitive Disorders
Overview of Alzheimer's Disease and Related Economic Burden
- 2025 report highlights the economic burden of Alzheimer's disease and its impact on society.
- Alzheimer's disease is described as a public health crisis due to increasing prevalence and risks associated with aging.
Population Aging and Cognitive Disorders
Population Aging
- Significant increase in the population aged 75 and older correlates with higher risks of neurocognitive disorders (NCDs).
- Awareness needed regarding aging and cognitive function.
Myths vs. Reality
- Common stereotype: Aging leads to cognitive decline (dementia).
- Research Findings:
- About 95% of individuals aged 71-79 are free from dementia.
- Approximately 85% of those aged 80-89 do not have dementia.
- Crisis Context: Although rising cases of dementia present a public health concern, cognitive decline is not inevitable.
Delirium
- Definition: An acute, fluctuating disturbance in attention and awareness that develops within hours.
- Linked Factors:
- Associated with infections (e.g., UTIs in older adults), medication changes, or metabolic imbalances.
- Symptoms:
- Fluctuating alertness: An individual may appear alert one moment and confused shortly after.
- Clinical Approach:
- Key mantra: "Delirium unless proven otherwise" emphasizes the need to identify delirium before considering dementia.
Neurocognitive Disorders (NCDs)
- Dementia:
- Defined as a severe cognitive decline impacting an individual's capability to live independently.
- DSM-5: Introduced neurocognitive disorders as a broader diagnostic category, recognizing various conditions leading to cognitive impairment.
- Classification:
- Major Neurocognitive Disorder (NCD): Significant cognitive decline affecting daily functioning (e.g., managing finances, medications).
- Mild Neurocognitive Disorder (mild NCD): Modest decline, but individual retains ability to function independently with compensatory strategies.
Mild Cognitive Impairment (MCI)
- MCI is a transitional state between normal cognitive aging and more severe impairments such as dementia.
- Key Takeaway: Less than 15% of individuals with MCI progress to dementia; MCI does not predict dementia.
- Subtypes:
- Amnestic MCI: Memory impairment is the primary concern.
- Non-amnestic MCI: Other cognitive domains such as language or executive function are more affected.
Prevalence and Risk Factors for Dementia
- Prevalence: Approximately 16% of individuals aged 70+ in the U.S. are diagnosed with dementia.
- Health Disparities:
- Incidence is higher in Black and Hispanic populations — up to three times greater for Black adults.
- Systemic factors contribute to varied risk and diagnosis rates.
- Gender Differences: Women generally exhibit higher rates of dementia than men, potentially due to hormonal factors.
Alzheimer's Disease
- Most Common Cause of Dementia:
- Recognized as a significant cause of mortality with no current cure.
- Neuropathological Hallmarks:
- Amyloid Plaques: Extracellular deposits of two types of amyloid beta (AB 40 and AB 42). The ratio of these peptides can indicate disease progression.
- Neurofibrillary Tangles: Intracellular accumulations of tau protein, leading to neuron death and cognitive decline.
Disease Progression
- Progressive and insidious decline in cognitive abilities, often starting with memory impairment due to hippocampal changes.
- Cognitive deficits can include…
- Language impairments (difficulty finding words).
- Executive function impairment (planning, decision-making).
Genetic Factors and Alzheimer's Risk
- Early-Onset Familial Alzheimer's Disease: Rare, typically attributed to specific gene mutations.
- APOE Dimensions:
- APOE ε4 allele as a genetic risk factor for late-onset Alzheimer's; however, not deterministic.
- Lifestyle factors (diet, exercise, emotional well-being) play significant roles alongside genetics.
Current Research and Biomarkers
- Advancements in Biomarkers:
- Use of PET scans and blood tests to measure amyloid plaques and tau tangles.
- Neurofilament light (NFL) as a non-diagnostic marker indicating brain inflammation.
- Constraints: Unequal access to biomarker research and therapies across demographic groups.
Other Causes of Dementia
- Lewy Body Disease: Symptoms include fluctuating cognition, visual hallucinations, and movement issues.
- Vascular Dementia: Caused primarily by strokes, characterized by stepwise cognitive decline tied to cerebrovascular events.
- Frontotemporal Dementia (FTD): Early onset and notable changes in personality, language, and social conduct; presents in the 50s compared to Alzheimer's, commonly seen in older adults.
Implications for Practice and Research
- Importance of understanding socio-economic contexts and health disparities when conducting research or clinical evaluations.
- Recommendations for culturally informed care and awareness of neurocognitive health and its determinants throughout the lifespan.
Conclusion
- Recognizing that dementia is not an inescapable outcome of aging and that most older adults can maintain cognitive health.
- Early diagnosis is crucial for appropriate planning and access to resources.